dcTRAILR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of monoclonal dcTRAILR antibodies for advanced research in apoptosis and immune regulation. Monoclonal dcTRAILR antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). dcTRAILR, also known as death receptor 4 (DR4), plays a critical role in mediating apoptosis through its interaction with TRAIL (TNF-related apoptosis-inducing ligand). dcTRAILR is essential for regulating immune responses and has significant implications in cancer therapy, as it can influence tumor cell sensitivity to apoptosis. Understanding dcTRAILR function is crucial for developing targeted treatments and therapeutic strategies in oncology. Researchers investigating dcTRAILR can explore its role in various cellular pathways and signaling mechanisms. The molecular interactions of dcTRAILR provide valuable information about cell death regulation and immune system function. Advanced research techniques using dcTRAILR monoclonal antibodies help identify potential therapeutic targets in cancer treatment. Santa Cruz Biotechnology monoclonal dcTRAILR antibodies enable researchers to advance scientific understanding of apoptosis pathways and contribute to the development of new therapeutic approaches.